Verastem Oncology
Verastem Oncology is a biopharmaceutical company that focuses on the development and commercialization of drugs to treat cancer. The company was founded in 2010 and is headquartered in Boston, Massachusetts, United States.
History
Verastem Oncology was founded by three scientists from the Massachusetts Institute of Technology (MIT): Robert Weinberg, Eric Lander, and Piyush Gupta. The company was established with the goal of developing new therapies for the treatment of cancer, specifically focusing on cancer stem cells.
Research and Development
Verastem Oncology's research and development efforts are primarily focused on the discovery and development of small molecule drugs that target cancer stem cells. These cells are believed to be responsible for the growth and spread of cancer, and are often resistant to traditional cancer treatments. Verastem Oncology's approach aims to target and kill these cells, potentially leading to more effective treatments for cancer.
The company's lead product candidate is defactinib, a small molecule inhibitor of the FAK and PYK2 signaling pathways, which are believed to play a critical role in the survival and proliferation of cancer stem cells. Defactinib is currently in clinical trials for the treatment of several types of cancer, including mesothelioma, non-small cell lung cancer, and pancreatic cancer.
Partnerships and Collaborations
Verastem Oncology has entered into several partnerships and collaborations to advance its research and development efforts. These include collaborations with Bristol-Myers Squibb, Merck, and the Cancer Research UK.
Financials
As a publicly traded company, Verastem Oncology's financial performance is reported on a quarterly and annual basis. The company's revenue primarily comes from the sale of its approved drugs, as well as from partnerships and collaborations.
See Also
References
<references />
Ad. Transform your life with W8MD's Budget GLP-1 injections from $29.99
W8MD offers medical weight loss programs including NYC medical weight loss and Philadelphia medical weight loss offering:
- Affordable GLP1 shots (generic and brand names) such as
- Wegovy NYC (Semaglutide)
- Zepbound NYC /
- Learn more: Budget GLP1 weight loss injections NYC & Philadelphia GLP1 weight loss shots
- Most insurances accepted
- Lowest cost GLP1 weight loss NYC such as Semaglutide starting from $29.99/week and $45.00/week (Tirzepatide) with insurance.
- Prescription weight loss NYC including:
NYC weight loss doctor appointmentsNYC weight loss doctor appointments
Start your physician weight loss journey today at our:
- NYC medical weight loss
- Philadelphia medical weight loss
- Call 718-946-5500 for NYC or 215-676-2334 for Philadelphia
- Tags:
Budget glp1 weight loss NYC,
Zepbound NYC,
Philadelphia medical weight loss,
Wegovy NYC,
Budget Zepbound Philadelphia,
[** https://w8md.org/?page_id=62216 Affordable glp1 shots Philadelphia]
Advertise on WikiMD
|
WikiMD's Wellness Encyclopedia |
| Let Food Be Thy Medicine Medicine Thy Food - Hippocrates |
Medical Disclaimer: WikiMD is not a substitute for professional medical advice. The information on WikiMD is provided as an information resource only, may be incorrect, outdated or misleading, and is not to be used or relied on for any diagnostic or treatment purposes. Please consult your health care provider before making any healthcare decisions or for guidance about a specific medical condition. WikiMD expressly disclaims responsibility, and shall have no liability, for any damages, loss, injury, or liability whatsoever suffered as a result of your reliance on the information contained in this site. By visiting this site you agree to the foregoing terms and conditions, which may from time to time be changed or supplemented by WikiMD. If you do not agree to the foregoing terms and conditions, you should not enter or use this site. See full disclaimer.
Credits:Most images are courtesy of Wikimedia commons, and templates, categories Wikipedia, licensed under CC BY SA or similar.
Translate this page: - East Asian
中文,
日本,
한국어,
South Asian
हिन्दी,
தமிழ்,
తెలుగు,
Urdu,
ಕನ್ನಡ,
Southeast Asian
Indonesian,
Vietnamese,
Thai,
မြန်မာဘာသာ,
বাংলা
European
español,
Deutsch,
français,
Greek,
português do Brasil,
polski,
română,
русский,
Nederlands,
norsk,
svenska,
suomi,
Italian
Middle Eastern & African
عربى,
Turkish,
Persian,
Hebrew,
Afrikaans,
isiZulu,
Kiswahili,
Other
Bulgarian,
Hungarian,
Czech,
Swedish,
മലയാളം,
मराठी,
ਪੰਜਾਬੀ,
ગુજરાતી,
Portuguese,
Ukrainian
